Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
Our AI ranks Msa Safety Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Msa Safety Inc is a mid-cap company with a market capitalization of $6.91B. It ranks number 6 by market capitalization among the 27 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast. Its ROE of 22.4% is the highest of the 19 peers that report one.
For MSA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 49.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 18.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.1%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, MSA included.
Follow MSA free90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
| Metric | MSA | Rank |
|---|---|---|
| Market Cap | $6.91B | 6/27 |
| P/E Ratio | 22.24x | 5/9 |
| P/B Ratio | 4.93x | 7/22 |
| Dividend Yield | 1.20% | – |
| EPS | $8.05 | – |
| Book Value/Share | $36.33 | – |
| Revenue/Share | $50.45 | – |
| FCF/Share | $9.18 | – |
| Metric | MSA | Rank |
|---|---|---|
| ROE | 22.4% | 1/19 |
| ROA | 12.1% | 2/19 |
| ROIC | 17.9% | 5/22 |
| Gross Margin | 47.6% | 11/20 |
| Operating Margin | 21.2% | 2/21 |
| Net Margin | 16.1% | 2/17 |
| EBT Margin | 21.1% | 2/21 |
| Tax Rate | 23.4% | – |
| Metric | MSA | Rank |
|---|---|---|
| Current Ratio | 3.24x | 8/25 |
| Quick Ratio | 2.02x | 10/22 |
| D/E Ratio | 0.86x | 10/24 |
| Financial Leverage | 1.86x | 10/24 |
| Interest Coverage | 3.5x | 5/21 |
| Working Capital | $646M | 6/25 |
| Metric | MSA | Rank |
|---|---|---|
| Operating Cash Flow | $406M | 6/25 |
| Free Cash Flow | $354M | 4/16 |
| Capital Spending | -$52M | 12/16 |
| OCF Growth YoY | 26.3% | 5/10 |
| FCF Growth YoY | 40.3% | 5/7 |
| FCF/Sales | 18.2% | 2/16 |
| CapEx/Sales | 2.6% | 6/16 |
| Metric | MSA | Rank |
|---|---|---|
| Asset Turnover | 0.75x | 7/18 |
| Receivables Turnover | 5.6x | 9/17 |
| Inventory Turnover | 2.9x | 10/22 |
| Fixed Assets Turnover | 7.0x | 9/19 |
| Days Sales Outstanding | 65 days | 9/17 |
| Days Inventory | 125 days | 13/22 |
| Payables Period | 44 days | 13/19 |
| Cash Conversion Cycle | 146 days | 7/15 |
| Metric | MSA | Rank |
|---|---|---|
| Total Revenue | $1.95B | 5/19 |
| Operating Income | $413M | 6/25 |
| Net Income | $314M | 5/19 |
| R&D Expense | $68M | 8/22 |
| SG&A Expense | $430M | 7/22 |
| Cost of Goods Sold | $1.02B | 6/22 |
| Metric | MSA | Rank |
|---|---|---|
| Dividends Per Share | $2.15 | – |
| Payout Ratio | 26.7% | – |
| Shares Outstanding | 39M | – |
| Net Income Growth | 13.4% | 4/7 |
| EPS Growth | 14.8% | 5/8 |
| Total Current Assets | $935M | 35.9% of assets |
| Cash & Short-term Investments | $200M | 7.7% of assets |
| Accounts Receivable | $348M | 13.4% of assets |
| Inventory | $350M | 13.5% of assets |
| Total Liabilities | $1.20B | 46.1% of assets |
| Short-term Debt | $165M | 6.4% of assets |
Companies classified under the same SEC industry code as Msa Safety Inc (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| MSA Msa Safety Inc | ▼ | $6.91B |
| ISRG Intuitive Surgical Inc | ▼ | $150.74B |
| STE Steris Plc | ▼ | $21.71B |
| ZBH Zimmer Biomet Holdings, Inc. | ▼ | $18.12B |
| SNN Smith & Nephew Plc | ▼ | $12.75B |
| ALGN Align Technology Inc | ▶ | $10.46B |
| ESTA Establishment Labs Holdings Inc. | ▲ | $1.76B |
| ENOV Enovis Corp | ▶ | $1.13B |
| CDRE Cadre Holdings, Inc. | ▶ | $1.13B |
| AVR Anteris Technologies Global Corp. | ▶ | $590M |
| SMTI Sanara Medtech Inc. | ▼ | $305M |
| INGN Inogen Inc | ▶ | $166M |
| LAKE Lakeland Industries Inc | ▲ | $90M |
| NTRB Nutriband Inc. | ▲ | $76M |
| APT Alpha Pro Tech Ltd | ▶ | $57M |
| COCH Envoy Medical, Inc. | ▶ | $52M |
| MYO Myomo, Inc. | ▲ | $48M |
| MLSS Milestone Scientific Inc. | ▲ | $29M |
| LFWD Lifeward Ltd. | ▲ | $17M |
| UEEC United Health Products, Inc. | ▲ | $13M |
| CUPR Cuprina Holdings (Cayman) Ltd | ▶ | $13M |
| RGNT Regentis Biomaterials Ltd. | ▲ | $10M |
| CLGN Collplant Biotechnologies Ltd | ▶ | $7M |
| LGMK Logicmark, Inc. | ▲ | $1M |
| BBLG Bone Biologics Corp | ▲ | $1M |
| RBOT Vicarious Surgical Inc. | ▲ | $550K |
| FEED Envue Medical, Inc. | ▼ | $340K |
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
PITTSBURGH, May 14, 2026 /PRNewswire/ -- The Board of Directors of MSA Safety Inc. (NYSE: MSA) has elected Robert A. Bruggeworth to the position of Chairman of the Board effective May 8, 2026, ...
Our AI ranks Msa Safety Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
For MSA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 49.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 18.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Msa Safety Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
27 issuers in our coverage, MSA included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew Plc (SNN), Align Technology Inc (ALGN), Establishment Labs Holdings Inc. (ESTA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.